Aether Industries Ltd
Incorporated in 2013, Aether Industries Limited is a manufacturer of specialty chemicals. The company is sole Indian manufacturer for chemicals such as 4-(2-Methoxyethyl) Phenol (4MEP), and 3-Methoxy-2-Methylbenzoyl Chloride (MMBC), Thiophene-2-Ethanol (T2E), Ortho Tolyl Benzo Nitrile (OTBN), N-Octyl-D-Glucamine, Delta-Valerolactone, and Bifenthrin Alcohol.[1]
- Market Cap ₹ 12,101 Cr.
- Current Price ₹ 913
- High / Low ₹ 1,136 / 762
- Stock P/E 130
- Book Value ₹ 156
- Dividend Yield 0.00 %
- ROCE 7.52 %
- ROE 5.61 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 5.86 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|
590 | 651 | 598 | |
422 | 465 | 466 | |
Operating Profit | 168 | 186 | 132 |
OPM % | 28% | 29% | 22% |
7 | 17 | 25 | |
Interest | 13 | 5 | 9 |
Depreciation | 15 | 23 | 40 |
Profit before tax | 146 | 174 | 110 |
Tax % | 26% | 25% | 25% |
109 | 130 | 82 | |
EPS in Rs | 9.67 | 10.47 | 6.22 |
Dividend Payout % | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -8% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -28% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -14% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 6% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|
Equity Capital | 113 | 125 | 133 |
Reserves | 274 | 1,120 | 1,931 |
291 | 16 | 183 | |
92 | 120 | 154 | |
Total Liabilities | 770 | 1,380 | 2,401 |
257 | 646 | 860 | |
CWIP | 58 | 37 | 226 |
Investments | 17 | 1 | 0 |
438 | 695 | 1,315 | |
Total Assets | 770 | 1,380 | 2,401 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|
-5 | -7 | -16 | |
-151 | -348 | -424 | |
169 | 439 | 894 | |
Net Cash Flow | 12 | 84 | 453 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|
Debtor Days | 101 | 145 | 142 |
Inventory Days | 221 | 301 | 391 |
Days Payable | 95 | 99 | 118 |
Cash Conversion Cycle | 227 | 348 | 415 |
Working Capital Days | 183 | 269 | 384 |
ROCE % | 18% |
Documents
Announcements
- Board Meeting Intimation for The Meeting To Be Held On July 19, 2024 13h
- Execution And Commissioning Of 5 MW Solar Power Project (Auto-Tracker Modules) Facility 2d
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
28 Jun - With reference to the intimation dated June 22, 2024 submitted vide Ref. No. AIL/SE/18/2024-25, in accordance with Regulation 30 and all other applicable provisions of …
-
Execution Of Strategic Supply Agreement With Baker Hughes
28 Jun - In accordance with Regulation 30 of the SEBI (LODR) Regulations, 2015, we herewith submit the details of the execution of the Strategic Supply Agreement (of …
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
22 Jun - In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended from time to time, we hereby submit the …
Concalls
-
May 2024Transcript PPT
-
May 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Jul 2023Transcript PPT
-
Jun 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Jan 2023Transcript PPT
-
Jan 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Jul 2022Transcript PPT
-
Jun 2022Transcript PPT
Business Segments FY24[1]
Large Scale Manufacturing (59%) Advanced intermediates and specialty chemicals with application across the industry spectrum.
Contract Manufacturing (26%)
Manufacture under contractual supply agreements with MNCs.
CRAMS (14%)
Contract research, scale-up services, technology development, low volume high-value contract manufacturing.